A phase 1 basket trial of CHM 1101 in solid tumours
Latest Information Update: 08 Dec 2021
Price :
$35 *
At a glance
- Drugs CHM 1101 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 30 Nov 2021 According to an Chimeric Therapeutics media release, this trial is expected to begin in 2022.
- 31 Aug 2021 New trial record